Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-11-07

FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth Pharmaceuticals (Pfizer) for updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREMARIN VAGINAL (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN VAGINAL (CONJUGATED ESTROGENS)